To assess the effect of the ultrashort-acting beta blocker esmolol on ischemia induced by
acute coronary occlusion, we studied 16 patients undergoing coronary angioplasty. Doppler …

The hypothesis that acute myocardial infarction (Ml) is more extensive in patients without
previous angina or healed MI was evaluated in 177 patients with documented recent acute …

Рассмотрены основные вопросы эпидемиологии и стратификации риска внезапной
сердечной смерти (ВСС). Показано, что наиболее эффективным методом …

Beta-blockers significantly decrease the risk of mortality in patients after myocardial
infarction (MI). Furthermore, beta-blockers reduce the risk of reinfarction and mortality in both …

Исследования в общей популяции, у лиц пожилого возраста, а также в группах больных
с артериальной гипертензией, инфарктом миокарда, стабильной коронарной …

Elderly patients are at greater risk for adverse drug effects than younger peo-ple. Advanced
age, use of multiple medications, 1, 2 coexisting conditions, 2 low body weight and being a …

In the last year, two large randomized controlled trials of metoprolol (MIAMI, almost 6,000
patients) and atenolol (ISIS 1, over 16,000 patients) given intravenously within 12 hours of …

A questionnaire survey based on hypertension case histories was performed among a
representative sample of 400 GP's and hospital doctors in Northern Ireland, Norway and …

The discovery that β blockers possess clinically useful hypotensive, antianginal and
antiarrhythmic properties has attracted the interest of clinicians, researchers and the …

The present study evaluated and compared subjective symptoms in hypertensive patients
(N= 83) at therapeutically comparable dosages of a new controlled release (CR/ZOK) …